Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Memphasys.
RELATED STOCKHEAD STORIES
Tech
Hydrix tries to cut through complexity with promises of $$$
Health & Biotech
Check up: Health stocks firing on excitement… and little else
Health & Biotech
Medtech needs more than a TGA tick to hit the big $$$
Health & Biotech
Health Kick Podcast: Memphasys is using electrical forces on sperm to get better IVF results
Health & Biotech
Health: Compumedics wins FDA approval for its brain scanners, leaps +20pc
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
9 of the most interesting biotech bosses in the game: part 2
Health & Biotech
Dr Boreham’s Crucible: Memphasys now feeling the investor love for its IVF tech
Health & Biotech
Health & Biotech: Mesoblast still not in the black, but they’re less in the red than last year
Director Trades
Director Trades: The people with the perfect timing
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Tim Boreham: Sperm sorter Memphasys is finding its feet as a grower, not a shower
Health & Biotech
This health small cap has grown by more than 8000pc in the last decade
News
It’s hard to pick a winner right now, but these 6 small caps are up 150pc since October
Health & Biotech
Guys, you could be using Memphasys’s sperm separator by next year
Tech